Secondary IgA Nephropathy

Overview

Journal Kidney Int

Publisher Elsevier

Specialty Nephrology

Date 2018 May 29

PMID 29804660

Citations 59

Authors

Manish K Saha

Bruce A Julian

Jan Novak

Dana V Rizk

Affiliations

Soon will be listed here.

Abstract

IgA nephropathy is the most common primary glomerulonephritis worldwide. Its frequent coexistence with inflammatory, infectious, or malignant processes raises the possibility of a pathologic rather than coincidental association. Major strides have been made to elucidate the underlying pathophysiologic events that culminate in the development of primary IgA nephropathy. Whether secondary forms of the disease share common pathways triggered by underlying disorders or different mechanisms leading to similar pathologic findings remains to be determined. In this article we describe the most frequent etiologies for secondary IgA nephropathy and review the available literature for the pathophysiology.

Citing Articles

Exploring the causal association between circulating leukocyte count and IgA nephropathy based on two-sample Mendelian randomization: possible role of transitional B cells.

Fang F, Wang H, Luo J, Hong F Clin Exp Nephrol. 2025; .

PMID: 40011364 DOI: 10.1007/s10157-025-02646-3.

Rapidly Progressive Glomerulonephritis Due to IgA Nephropathy in a Patient With a Large Renal Mass.

Shi D, Ghias M, Bogdansky K, Haris A Cureus. 2025; 16(12):e76015.

PMID: 39834951 PMC: 11743532. DOI: 10.7759/cureus.76015.

IgA vasculitis with nephritis accompanied by pulmonary tuberculosis: a case report.

Abe E, Kobayashi R, Matsuoka R, Kanaoka T, Yamanaka S, Fujii S CEN Case Rep. 2025; .

PMID: 39786654 DOI: 10.1007/s13730-025-00966-7.

Post-transplant IgA nephropathy: a rapidly evolving field of kidney transplant medicine.

Kanbay M, Ozbek L, Guldan M, Copur S, Barratt J J Nephrol. 2024; .

PMID: 39565563 DOI: 10.1007/s40620-024-02149-6.

Rapidly Progressive Glomerulonephritis Associated With IgA Nephropathy and C3 Deposits in a Patient With Chronic Hepatitis B.

Wiese J, Derian N, Turki M, Joshi T, Alsanani A, Satoskar A Cureus. 2024; 16(10):e70619.

PMID: 39483559 PMC: 11526628. DOI: 10.7759/cureus.70619.

References

Endo Y, Hara M . Glomerular IgA deposition in pulmonary diseases. Kidney Int. 1986; 29(2):557-62. DOI: 10.1038/ki.1986.34. View

Wilson F, Nasr S, Markowitz G, Naylor E, Sterman P, DAgati V . A destructive nasal lesion and glomerulonephritis. Kidney Int. 2006; 69(9):1699-703. DOI: 10.1038/sj.ki.5000282. View

Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T . IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018; 93(3):700-705. DOI: 10.1016/j.kint.2017.10.019. View

Smith A, Molyneux K, Feehally J, Barratt J . O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol. 2006; 17(12):3520-8. DOI: 10.1681/ASN.2006060658. View

Wang N, Wu Z, Zhang Y, Liao L . Existence and significance of hepatitis B virus DNA in kidneys of IgA nephropathy. World J Gastroenterol. 2005; 11(5):712-6. PMC: 4250745. DOI: 10.3748/wjg.v11.i5.712. View

Kutteh W, Prince S, Phillips J, Spenney J, Mestecky J . Properties of immunoglobulin A in serum of individuals with liver diseases and in hepatic bile. Gastroenterology. 1982; 82(2):184-93. View

Berthelot L, Papista C, Maciel T, Biarnes-Pelicot M, Tissandie E, Wang P . Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med. 2012; 209(4):793-806. PMC: 3328362. DOI: 10.1084/jem.20112005. View

HIKI Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H . Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 2001; 59(3):1077-85. DOI: 10.1046/j.1523-1755.2001.0590031077.x. View

Koyama A, Sharmin S, Sakurai H, Shimizu Y, Hirayama K, Usui J . Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int. 2004; 66(1):121-32. DOI: 10.1111/j.1523-1755.2004.00714.x. View

10.

Mestecky J, Novak J, Moldoveanu Z, Raska M . IgA nephropathy enigma. Clin Immunol. 2016; 172:72-77. PMC: 5159197. DOI: 10.1016/j.clim.2016.07.011. View

11.

Pouria S, Barratt J . Secondary IgA nephropathy. Semin Nephrol. 2008; 28(1):27-37. DOI: 10.1016/j.semnephrol.2007.10.004. View

12.

Buren M, Yamashita M, Suzuki Y, Tomino Y, Emancipator S . Altered expression of lymphocyte homing chemokines in the pathogenesis of IgA nephropathy. Contrib Nephrol. 2007; 157:50-5. DOI: 10.1159/000102304. View

13.

Baenziger J, Fiete D . Galactose and N-acetylgalactosamine-specific endocytosis of glycopeptides by isolated rat hepatocytes. Cell. 1980; 22(2 Pt 2):611-20. DOI: 10.1016/0092-8674(80)90371-2. View

14.

Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr A, Renfrow M . The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011; 22(10):1795-803. PMC: 3892742. DOI: 10.1681/ASN.2011050464. View

15.

Bu R, Li Q, Duan Z, Wu J, Chen P, Chen X . Clinicopathologic features of IgA-dominant infection-associated glomerulonephritis: a pooled analysis of 78 cases. Am J Nephrol. 2015; 41(2):98-106. DOI: 10.1159/000377684. View

16.

Fellstrom B, Barratt J, Cook H, Coppo R, Feehally J, De Fijter J . Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Lancet. 2017; 389(10084):2117-2127. DOI: 10.1016/S0140-6736(17)30550-0. View

17.

Tissandie E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F . Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Kidney Int. 2011; 80(12):1352-63. DOI: 10.1038/ki.2011.276. View

18.

Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M . Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet. 2014; 46(11):1187-96. PMC: 4213311. DOI: 10.1038/ng.3118. View

19.

Batra A, Smith A, Feehally J, Barratt J . T-cell homing receptor expression in IgA nephropathy. Nephrol Dial Transplant. 2007; 22(9):2540-8. DOI: 10.1093/ndt/gfm228. View

20.

Stirati G, Antonelli M, Fofi C, Fierimonte S, PECCI G . IgA nephropathy in cystic fibrosis. J Nephrol. 1999; 12(1):30-1. View